Relationship between menarche age and parity with the incidence of uterine myomas
Abstract
Background: Uterine myomas, or fibroids, are one of the most common benign tumors that occur in women of reproductive age, with a reasonably high prevalence worldwide. However, rarely, potentially malignant uterine myomas can cause a variety of health problems, including excessive menstruation, pelvic pain, fertility disorders, and pregnancy complications.
Objective: This study aims to analyze the relationship between menarche age and parity with the incidence of uterine myoma.
Methods: Types and design of research the plan used in this exploration is quantitative exploration with a case control approach. The sample consisted of 138 respondents, 102 of whom were mothers who experienced uterine myoma and 36 mothers who did not experience the adverse effects of uterine myoma.
Results: The test results measured using the chi-square test were obtained with p-value menarche age = 0.004 and parity p-value = 0.000, meaning that there was a very large relationship between menarche age and parity with the incidence of uterine myomas.
Conclusion: It can be concluded that the earlier the age of menarche increases the risk of uterine myoma later in life. In contrast, slower menarche may be associated with a reduced risk of myomas. Other factors such as genetic, environmental, and lifestyle factors also influence the incidence of uterine myomas, but menarche age is one of the significant hormonal indicators of risk
Downloads
References
Agbayani Cruz, C. T. A. and Bucu, M. E. M. (2024) ‘Clinical profile and symptoms of young women aged 10–24 years diagnosed with pelvic endometriosis: a 5-year experience of a tertiary hospital in the Philippines’, Journal of Endometriosis and Uterine Disorders, 8, p. 100085. doi: https://doi.org/10.1016/j.jeud.2024.100085.
Charifson, M. A. et al. (2022) ‘Why are Black individuals disproportionately burdened with uterine fibroids and how are we examining this disparity? A systematic review’, F&S Reviews, 3(4), pp. 256–279. doi: https://doi.org/10.1016/j.xfnr.2022.07.004.
Coutinho, L. M. et al. (2022) ‘Uterine Fibroids and Pregnancy: How Do They Affect Each Other?’, Reproductive Sciences, 29(8), pp. 2145–2151. doi: https://doi.org/10.1007/s43032-021-00656-6.
Dolmans, M.-M. et al. (2024) ‘Pathogenesis of uterine fibroids: current understanding and future directions’, Fertility and Sterility, 122(1), pp. 6–11. doi: https://doi.org/10.1016/j.fertnstert.2024.02.048.
Dolmans, M.-M. and Donnez, J. (2024) ‘Solving the mysteries surrounding uterine fibroids: are we almost there?’, Fertility and Sterility, 122(1), pp. 4–5. doi: 10.1016/j.fertnstert.2024.05.144.
Farkas, A. H., Abumusa, H. and Rossiter, B. (2023) ‘Structural Gynecological Disease’, Medical Clinics of North America, 107(2), pp. 317–328. doi: https://doi.org/10.1016/j.mcna.2022.10.010.
Farooq, H. et al. (2024) ‘A systematic review of association between use of hair products and benign and malignant gynecological conditions’, European Journal of Obstetrics & Gynecology and Reproductive Biology, 295, pp. 160–171. doi: https://doi.org/10.1016/j.ejogrb.2024.02.012.
Hafid, A., Rodiani, R. and Sayuti, M. (2023) ‘Amenorea Primer et Hematokolpos et Hematometra ec. Septum Vagina Transversal’, Jurnal Ilmiah Kesehatan Sandi Husada, 12(1), pp. 55–60. doi: https://doi.org/10.35816/jiskh.v12i1.867.
Hill, S. and Shetty, M. K. (2023) ‘Abnormal Uterine Bleeding in Reproductive Age Women: Role of Imaging in the Diagnosis and Management’, Seminars in Ultrasound, CT and MRI, 44(6), pp. 511–518. doi: https://doi.org/10.1053/j.sult.2023.10.002.
Kim, S. et al. (2023) ‘Alcohol consumption and the risk of new-onset uterine leiomyomas: a nationwide population-based study in 2.5 million Korean women aged 20 to 39 years’, American Journal of Obstetrics and Gynecology, 229(1), pp. 45.e1-45.e18. doi: https://doi.org/10.1016/j.ajog.2023.03.041.
Kwinten, K. J. J. et al. (2023) ‘Yield of annual endometrial cancer surveillance in women with PTEN Hamartoma Tumor Syndrome’, European Journal of Medical Genetics, 66(7), p. 104785. doi: https://doi.org/10.1016/j.ejmg.2023.104785.
Li, J. et al. (2024) ‘Phthalate metabolites in urine and follicular fluid in relation to menstrual cycle characteristics in women seeking fertility assistance’, Environment International, 183, p. 108362. doi: https://doi.org/10.1016/j.envint.2023.108362.
Mension, E. et al. (2024) ‘An update on the management of uterine fibroids: personalized medicine or guidelines?’, Journal of Endometriosis and Uterine Disorders, 7, p. 100080. doi: https://doi.org/10.1016/j.jeud.2024.100080.
Pandey, V. et al. (2024) ‘Variants in exon 2 of MED12 gene causes uterine leiomyoma’s through over-expression of MMP-9 of ECM pathway’, Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 828, p. 111839. doi: https://doi.org/10.1016/j.mrfmmm.2023.111839.
Pavlik, T., Konchekov, E. and Shimanovskii, N. (2024) ‘Antitumor progestins activity: Cytostatic effect and immune response’, Steroids, 210, p. 109474. doi: https://doi.org/10.1016/j.steroids.2024.109474.
Petersdorf, K. et al. (2022) ‘Endometrial hyperplasia in pre-menopausal women: A systematic review of incidence, prevalence, and risk factors’, European Journal of Obstetrics & Gynecology and Reproductive Biology, 271, pp. 158–171. doi: https://doi.org/10.1016/j.ejogrb.2022.02.015.
Rault, E. et al. (2020) ‘Impact of history of myomectomy on preterm birth risk in women with a leiomyomatous uterus: a propensity score analysis’, BMC Pregnancy and Childbirth, 20(1), p. 720. doi: https://doi.org/10.1186/s12884-020-03413-w.
Roberts, E. et al. (2020) ‘Timing of menarche and self-harm in adolescence and adulthood: a population-based cohort study’, Psychological Medicine. 2019/08/28, 50(12), pp. 2010–2018. doi: https://doi.org/10.1017/S0033291719002095.
Santulli, P. et al. (2024) ‘Assessment of the Pelvic Pain Experienced by Infertile Women is of Prime Importance for Diagnosing Endometriosis’, Journal of Minimally Invasive Gynecology. doi: https://doi.org/10.1016/j.jmig.2024.07.010.
Song, S. et al. (2023) ‘Risk of uterine leiomyomata with menstrual and reproductive factors in premenopausal women: Korea nurses’ health study’, BMC Women’s Health, 23(1), p. 305. doi: https://doi.org/10.1186/s12905-023-02447-4.
Sun, F. et al. (2023) ‘Risk Factors for Symptomatic Recurrence after Laparoscopic Adenomyomectomy: A 3-Year Follow-up’, Journal of Minimally Invasive Gynecology, 30(7), pp. 555–561. doi: https://doi.org/10.1016/j.jmig.2023.03.001.
Vannuccini, S. et al. (2022) ‘From menarche to menopause, heavy menstrual bleeding is the underrated compass in reproductive health’, Fertility and Sterility, 118(4), pp. 625–636. doi: https://doi.org/10.1016/j.fertnstert.2022.07.021.
Wojtyła, C. et al. (2023) ‘European trends in ovarian cancer mortality, 1990–2020 and predictions to 2025’, European Journal of Cancer, 194, p. 113350. doi: https://doi.org/10.1016/j.ejca.2023.113350.
Yin, M. et al. (2023) ‘Long non coding RNA, C8orf49, a novel diagnostic and prognostic biomarker, enhances PTEN/FZD4-mediated cell growth and metastasis by sponging miR-1323 in endometriosis’, Molecular and Cellular Endocrinology, 575, p. 112040. doi: https://doi.org/10.1016/j.mce.2023.112040.
Yuliyanti, T., Kristiarini, J. J. and Suryantara, B. (2024) ‘The Effect of Post-Placental Intrauterine Contraceptive Devices on Decreasing in Uterine Fundus Height in Postpartum SC Mothers’, Jurnal Ilmiah Kesehatan Sandi Husada, 13(1), pp. 01–08. doi: https://doi.org/10.35816/jiskh.v13i1.1120.
Zhang, H. et al. (2024) ‘Phthalate exposure as a hidden risk factor for uterine leiomyoma in adult women: Accumulated evidence from observational studies’, Ecotoxicology and Environmental Safety, 285, p. 117069. doi: https://doi.org/10.1016/j.ecoenv.2024.117069.
Zhang, J. et al. (2024) ‘Developing a Predictive Model for Minimal or Mild Endometriosis as a Clinical Screening Tool in Infertile Women: Uterosacral Tenderness as a Key Predictor’, Journal of Minimally Invasive Gynecology, 31(3), pp. 227–236. doi: https://doi.org/10.1016/j.jmig.2023.12.008.
Zhou, X. et al. (2024) ‘Safety and effectiveness evaluation of a uterine direct visualization system in induced abortion. A multicenter clinical trial’, Taiwanese Journal of Obstetrics and Gynecology, 63(2), pp. 214–219. doi: https://doi.org/10.1016/j.tjog.2024.01.017
